Status:
COMPLETED
Long Term Effects of Hydroxyurea Therapy in Children With Sickle Cell Disease
Lead Sponsor:
St. Jude Children's Research Hospital
Collaborating Sponsors:
Children's Hospital Medical Center, Cincinnati
Conditions:
Sickle Cell Disease
Eligibility:
All Genders
Up to 30 years
Brief Summary
The primary objectives of this prospective, observational study are (1) to describe the long-term cellular, molecular, and clinical effects of hydroxyurea therapy in sickle cell disease, and (2) to pe...
Detailed Description
Many years of study have documented the severe effects of sickle cell disease. Some of these effects include hemolysis (the break down of red blood cells), blockages in the blood vessels, and damage t...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Patients from birth up to age 30 years
- Diagnosis of sickle cell disease
- Patients who are receiving hydroxyurea therapy or plan to begin hydroxyurea therapy
Exclusion
Key Trial Info
Start Date :
March 3 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 23 2015
Estimated Enrollment :
260 Patients enrolled
Trial Details
Trial ID
NCT00305175
Start Date
March 3 2006
End Date
April 23 2015
Last Update
July 28 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Jude Children's Research Hospital
Memphis, Tennessee, United States, 38105